{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:36:38Z","timestamp":1777055798587,"version":"3.51.4"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40257-024-00900-0","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T21:08:50Z","timestamp":1732223330000},"page":"45-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6052-9027","authenticated-orcid":false,"given":"Alexandra","family":"Dobre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-527X","authenticated-orcid":false,"given":"Roxana-Ioana","family":"Nedelcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-6066","authenticated-orcid":false,"given":"Gabriela","family":"Turcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7052-2830","authenticated-orcid":false,"given":"Alice","family":"Brinzea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Struna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Tudorache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alen","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ionela","family":"Hulea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Balasescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0251-3865","authenticated-orcid":false,"given":"Tudor Emanuel","family":"Fertig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6117-4328","authenticated-orcid":false,"given":"Mihaela","family":"Gherghiceanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-0965","authenticated-orcid":false,"given":"Catherine","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1031-7557","authenticated-orcid":false,"given":"Daniela Adriana","family":"Ion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-7883","authenticated-orcid":false,"given":"Ana-Maria","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"900_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jaad.2015.11.033","volume":"74","author":"B Kwiek","year":"2016","unstructured":"Kwiek B, Schwartz RA. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol. 2016;74:1220\u201333.","journal-title":"J Am Acad Dermatol"},{"key":"900_CR2","unstructured":"Zito PM, Scharf R. Keratoacanthoma. StatPearls; 2023. Available from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499931\/. Accessed 10 Feb 2024."},{"key":"900_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/bjd.20389","volume":"185","author":"A Tisack","year":"2021","unstructured":"Tisack A, Fotouhi A, Fidai C, Friedman BJ, Ozog D, Veenstra J. A clinical and biological review of keratoacanthoma. Br J Dermatol. 2021;185:487\u201398.","journal-title":"Br J Dermatol"},{"key":"900_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaad.2018.10.014","volume":"81","author":"SKT Que","year":"2019","unstructured":"Que SKT, Compton LA, Schmults CD. Eruptive squamous atypia (also known as eruptive keratoacanthoma): definition of the disease entity and successful management via intralesional 5-fluorouracil. J Am Acad Dermatol. 2019;81:111\u201322.","journal-title":"J Am Acad Dermatol"},{"key":"900_CR5","volume":"15","author":"PR Cohen","year":"2023","unstructured":"Cohen PR, Kurzrock R. Germline testing of mismatch repair genes is needed in the initial evaluation of patients with Muir-Torre syndrome-associated cutaneous sebaceous neoplasms: a case Series. Cureus. 2023;15: e33975.","journal-title":"Cureus"},{"key":"900_CR6","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/genes12081173","volume":"12","author":"MC Martens","year":"2021","unstructured":"Martens MC, Emmert S, Boeckmann L. Xeroderma pigmentosum: gene variants and splice variants. Genes (Basel). 2021;12:1173.","journal-title":"Genes (Basel)"},{"key":"900_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes11121410","volume":"11","author":"D Goudie","year":"2020","unstructured":"Goudie D. Multiple self-healing squamous epithelioma (MSSE): a digenic trait associated with loss of function mutations in TGFBR1 and variants at a second linked locus on the long arm of chromosome 9. Genes (Basel). 2020;11:1\u201312.","journal-title":"Genes (Basel)"},{"key":"900_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2016.09.001","volume":"167","author":"FL Zhong","year":"2016","unstructured":"Zhong FL, Mama\u00ef O, Sborgi L, Boussofara L, Hopkins R, Robinson K, et al. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell. 2016;167:187-202.e17.","journal-title":"Cell"},{"key":"900_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000018157","volume":"198","author":"M Agarwal","year":"1999","unstructured":"Agarwal M, Chander R, Karmakar S, Walia R. Multiple familial keratoacanthoma of Witten and Zak\u2014a report of three siblings. Dermatology. 1999;198:396\u20139. https:\/\/doi.org\/10.1159\/000018157.","journal-title":"Dermatology"},{"key":"900_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/bjs.1800540309","volume":"54","author":"EG Muir","year":"1967","unstructured":"Muir EG, Bell AJY, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg. 1967;54:191\u20135. https:\/\/doi.org\/10.1002\/bjs.1800540309.","journal-title":"Br J Surg"},{"key":"900_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/archderm.1968.01610170109024","volume":"98","author":"D Torre","year":"1968","unstructured":"Torre D. New York dermatological society. Arch Dermatol. 1968;98:549\u201352.","journal-title":"Arch Dermatol"},{"key":"900_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaad.2018.04.033","volume":"80","author":"CI Vidal","year":"2019","unstructured":"Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, et al. Appropriate use criteria in dermatopathology: initial recommendations from the American Society of Dermatopathology. J Am Acad Dermatol. 2019;80:189-207.e11.","journal-title":"J Am Acad Dermatol"},{"key":"900_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jaad.2015.09.074","volume":"74","author":"AM John","year":"2016","unstructured":"John AM, Schwartz RA. Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol. 2016;74:558\u201366.","journal-title":"J Am Acad Dermatol"},{"key":"900_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/path.5422","volume":"250","author":"G Cerretelli","year":"2020","unstructured":"Cerretelli G, Ager A, Arends MJ, Frayling IM. Molecular pathology of Lynch syndrome. J Pathol. 2020;250:518\u201331.","journal-title":"J Pathol"},{"key":"900_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/his.14044","volume":"76","author":"I Ferreira","year":"2019","unstructured":"Ferreira I, Wiedemeyer K, Demetter P, Adams DJ, Arends MJ, Brenn T. Update on the pathology, genetics and somatic landscape of sebaceous tumours. Histopathology. 2019;76:640\u20139.","journal-title":"Histopathology"},{"key":"900_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jaad.2023.01.035","volume":"88","author":"CS Zhong","year":"2023","unstructured":"Zhong CS, Horiguchi M, Uno H, Ukaegbu C, Chittenden A, LeBoeuf NR, et al. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort. J Am Acad Dermatol. 2023;88:1282\u201390.","journal-title":"J Am Acad Dermatol"},{"key":"900_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10689-022-00319-8","volume":"22","author":"S Aziz","year":"2023","unstructured":"Aziz S, O\u2019Sullivan H, Heelan K, Alam A, McVeigh TP. Characterization of sebaceous and non-sebaceous cutaneous manifestations in patients with lynch syndrome: a systematic review. Fam Cancer. 2023;22:167.","journal-title":"Fam Cancer"},{"key":"900_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2021.01.005","volume":"254\u2013255","author":"G Cini","year":"2021","unstructured":"Cini G, Carnevali I, Sahnane N, Chiaravalli AM, Dell\u2019Elice A, Maestro R, et al. Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3\u2019UTR of the MSH6 gene. Cancer Genet. 2021;254\u2013255:1\u201310.","journal-title":"Cancer Genet"},{"key":"900_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/ced.15008","volume":"47","author":"D Cino","year":"2022","unstructured":"Cino D, Drumm C, Sheahan K, D\u2019Arcy C, Nolan N, Hoti E, et al. Muir-Torre syndrome: a case of unusual coexisting genetic mutations. Clin Exp Dermatol. 2022;47:602\u20134. https:\/\/doi.org\/10.1111\/ced.15008.","journal-title":"Clin Exp Dermatol"},{"key":"900_CR20","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jdcr.2020.07.006","volume":"6","author":"R Zhang","year":"2020","unstructured":"Zhang R, Bhate C, Cai D. Genetic heterogeneity in a patient with Muir-Torre syndrome. JAAD Case Rep. 2020;6:886.","journal-title":"JAAD Case Rep"},{"key":"900_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/1346-8138.15772","volume":"48","author":"E Takayama","year":"2021","unstructured":"Takayama E, Yoshioka A, Takai T, Goto K. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type. J Dermatol. 2021;48:690\u20134. https:\/\/doi.org\/10.1111\/1346-8138.15772.","journal-title":"J Dermatol"},{"key":"900_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/DAD.0000000000000649","volume":"38","author":"D Kacerovska","year":"2016","unstructured":"Kacerovska D, Drlik L, Slezakova L, Michal M, Stehlik J, Sedivcova M, et al. Cutaneous sebaceous lesions in a patient with MUTYH-associated polyposis mimicking Muir-Torre Syndrome. Am J Dermatopathol. 2016;38:915\u201323.","journal-title":"Am J Dermatopathol"},{"key":"900_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/gim.2014.19","volume":"16","author":"ME Roberts","year":"2014","unstructured":"Roberts ME, Riegert-Johnson DL, Thomas BC, Rumilla KM, Thomas CS, Heckman MG, et al. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med. 2014;16:711\u20136.","journal-title":"Genet Med"},{"key":"900_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-2133.1934.tb09778.x","volume":"46","author":"JF Smith","year":"1934","unstructured":"Smith JF. A case of multiple primary squamous-celled carcinomata of the skin in a young man, with spontaneous healing. Br J Dermatol. 1934;46:267\u201372. https:\/\/doi.org\/10.1111\/j.1365-2133.1934.tb09778.x.","journal-title":"Br J Dermatol"},{"key":"900_CR25","unstructured":"Ferguson-Smith M, Goudie D. Orphanet\u2014multiple self-healing squamous epithelioma; 2015. Available from https:\/\/www.orpha.net\/en\/disease\/detail\/65748. Accessed 20 Sept 2024."},{"key":"900_CR26","first-page":"157","volume":"7","author":"MA Ferguson-Smith","year":"1971","unstructured":"Ferguson-Smith MA, Wallace DC, James ZH, Renwick JH. Multiple self-healing squamous epithelioma. Birth Defects Orig Artic Ser. 1971;7:157\u201363.","journal-title":"Birth Defects Orig Artic Ser"},{"key":"900_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jdcr.2018.05.010","volume":"4","author":"K Saleh","year":"2018","unstructured":"Saleh K, Gebre-Medhin S, Christensen G. Pancreatic cancer occurrence in Ferguson-Smith syndrome. JAAD Case Rep. 2018;4:565.","journal-title":"JAAD Case Rep"},{"key":"900_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6429","volume":"10","author":"N Litaiem","year":"2022","unstructured":"Litaiem N, Khammouma F, Mrad M, Bacha T, Kacem LB, Zeglaoui F. Multiple keratoacanthomas of Ferguson-Smith type. Clin Case Rep. 2022;10: e06429. https:\/\/doi.org\/10.1002\/ccr3.6429.","journal-title":"Clin Case Rep"},{"key":"900_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1067\/S0190-9622(03)00454-7","volume":"49","author":"N Kato","year":"2003","unstructured":"Kato N, Ito K, Kimura K, Shibata M. Ferguson Smith type multiple keratoacanthomas and a keratoacanthoma centrifugum marginatum in a woman from Japan. J Am Acad Dermatol. 2003;49:741\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"900_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng.780","volume":"43","author":"DR Goudie","year":"2011","unstructured":"Goudie DR, D\u2019Alessandro M, Merriman B, Lee H, Szever\u00e9nyi I, Avery S, et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet. 2011;43:365\u20139.","journal-title":"Nat Genet"},{"key":"900_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.biocel.2014.04.007","volume":"53","author":"MA Ferguson-Smith","year":"2014","unstructured":"Ferguson-Smith MA, Goudie DR. Digenic\/multilocus aetiology of multiple self-healing squamous epithelioma (Ferguson-Smith disease): TGFBR1 and a second linked locus. Int J Biochem Cell Biol. 2014;53:520\u20135.","journal-title":"Int J Biochem Cell Biol"},{"key":"900_CR32","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/jid.2013.45","volume":"133","author":"H Chung Kang","year":"2013","unstructured":"Chung Kang H, Quigley DA, Kim IJ, Wakabayashi Y, Ferguson-Smith MA, D\u2019Alessandro M, et al. Multiple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology. J Invest Dermatol. 2013;133:1907.","journal-title":"J Invest Dermatol"},{"key":"900_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGF-\u03b2 biology in cancer progression and tumor immunotherapy. Nat Rev Clin Oncol. 2021;18:9.","journal-title":"Nat Rev Clin Oncol"},{"key":"900_CR34","first-page":"6675208","volume":"2021","author":"Y Yang","year":"2021","unstructured":"Yang Y, Ye WL, Zhang RN, He XS, Wang JR, Liu YX, et al. The role of TGF-\u03b2 signaling pathways in cancer and its potential as a therapeutic target. Evid Based Complement Alternat Med. 2021;2021:6675208.","journal-title":"Evid Based Complement Alternat Med"},{"key":"900_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0092-8674(00)80127-0","volume":"86","author":"W Cui","year":"1996","unstructured":"Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A. TGF1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 1996;86:531\u201342.","journal-title":"Cell"},{"key":"900_CR36","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/sj.jid.5700914","volume":"127","author":"M D\u2019Alessandro","year":"2007","unstructured":"D\u2019Alessandro M, Coats SE, Morley SM, Mackintosh L, Tessari G, Turco A, et al. Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder? J Investig Dermatol. 2007;127:2336\u201344.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"900_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/1097-0142","volume":"5","author":"VH Witten","year":"1952","unstructured":"Witten VH, Zak FG. Multiple, primary, self-healing prickle-cell epithelioma of the skin. Cancer. 1952;5(3):539\u201350. https:\/\/doi.org\/10.1002\/1097-0142.","journal-title":"Cancer"},{"key":"900_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.clindermatol.2009.06.010","volume":"28","author":"CJ Ko","year":"2010","unstructured":"Ko CJ. Keratoacanthoma: facts and controversies. Clin Dermatol. 2010;28:254\u201361.","journal-title":"Clin Dermatol"},{"key":"900_CR39","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s13555-021-00502-2","volume":"11","author":"R Havenith","year":"2021","unstructured":"Havenith R, de Vos L, Fr\u00f6hlich A, Braegelmann C, Sirokay J, Landsberg J, et al. Grzybowski\u2019s generalized eruptive keratoacanthomas in a patient with terminal kidney disease\u2014an unmet medical need equally ameliorated by topical imiquimod cream and Lapacho tea wraps: a case report. Dermatol Ther (Heidelb). 2021;11:625.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"900_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s001050050219","volume":"46","author":"B Boateng","year":"1995","unstructured":"Boateng B, Hornstein OP, Von Den Driesch P. Kiesewetter F [Multiple keratoacanthomas (Witten-Zak type) in prurigo simplex subacuta]. Hautarzt. 1995;46:114\u20137.","journal-title":"Hautarzt"},{"key":"900_CR41","unstructured":"Hebra F, Kaposi M. On diseases of the skin including exanthemata. The New Sydenham Society;1874. p. 252\u20138. Available from https:\/\/books.google.ro\/books?hl=ro&lr=&id=Ely6-ZYJsGgC&oi=fnd&pg=PA1&ots=Bws9pxH3vf&sig=_zrxePOZqWEkYscDsH_m66otrxE&redir_esc=y#v=onepage&q&f=false"},{"key":"900_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jmg.2010.083022","volume":"48","author":"PT Bradford","year":"2011","unstructured":"Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterizes the role of DNA repair. J Med Genet. 2011;48:168.","journal-title":"J Med Genet"},{"key":"900_CR43","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1111\/bph.14557","volume":"176","author":"R Abeti","year":"2019","unstructured":"Abeti R, Zeitlberger A, Peelo C, Fassihi H, Sarkany RPE, Lehmann AR, et al. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms. Br J Pharmacol. 2019;176:4293.","journal-title":"Br J Pharmacol"},{"key":"900_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12105-016-0707-8","volume":"10","author":"JO Black","year":"2016","unstructured":"Black JO. Xeroderma pigmentosum. Head Neck Pathol. 2016;10:139.","journal-title":"Head Neck Pathol"},{"key":"900_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38311-0","author":"AA Yurchenko","year":"2023","unstructured":"Yurchenko AA, Rajabi F, Braz-Petta T, Fassihi H, Lehmann A, Nishigori C, et al. Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-38311-0.","journal-title":"Nat Commun"},{"key":"900_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2022-2-5","volume":"11","author":"A Leung","year":"2022","unstructured":"Leung A, Barankin B, Lam J, Leong KF, Hon KL. Xeroderma pigmentosum: an updated review. Drugs Context. 2022;11:1\u201317. https:\/\/doi.org\/10.7573\/dic.2022-2-5.","journal-title":"Drugs Context"},{"key":"900_CR47","first-page":"1153","volume":"38","author":"MC Martens","year":"2018","unstructured":"Martens MC, Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and skin cancer prevention strategies: an update. Anticancer Res. 2018;38:1153.","journal-title":"Anticancer Res"},{"key":"900_CR48","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2019.01.023","volume":"176","author":"JH Yoon","year":"2019","unstructured":"Yoon JH, McArthur MJ, Park J, Basu D, Wakamiya M, Prakash L, et al. Error-prone replication through UV lesions by DNA polymerase \u03b8 protects against skin cancers. Cell. 2019;176:1295.","journal-title":"Cell"},{"key":"900_CR49","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/jpm11111146","volume":"11","author":"M Piccione","year":"2021","unstructured":"Piccione M, Fortina AB, Ferri G, Andolina G, Beretta L, Cividini A, et al. Xeroderma pigmentosum: general aspects and management. J Pers Med. 2021;11:1146.","journal-title":"J Pers Med"},{"key":"900_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s42764-020-00009-8","volume":"1","author":"GP Pfeifer","year":"2020","unstructured":"Pfeifer GP. Mechanisms of UV-induced mutations and skin cancer. Genome Instab Dis. 2020;1:99.","journal-title":"Genome Instab Dis"},{"key":"900_CR51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2133.2004.06311.x","volume":"152","author":"AM Bhutto","year":"2005","unstructured":"Bhutto AM, Shaikh A, Nonaka S. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study. Br J Dermatol. 2005;152:545\u201351. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.06311.x.","journal-title":"Br J Dermatol"},{"key":"900_CR52","unstructured":"Kraemer KH, DiGiovanna JJ, Tamura D. Xeroderma pigmentosum. GeneReviews\u00ae; 2022."},{"key":"900_CR53","unstructured":"Lucero R, Horowitz D. Xeroderma pigmentosum. StatPearls; 2023. Available from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551563\/"},{"key":"900_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2019.108286","volume":"782","author":"A Zebian","year":"2019","unstructured":"Zebian A, Shaito A, Mazurier F, Rezvani HR, Zibara K. XPC beyond nucleotide excision repair and skin cancers. Mutat Res\/Rev Mutat Res. 2019;782: 108286.","journal-title":"Mutat Res\/Rev Mutat Res"},{"key":"900_CR55","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/jid.2010.352","volume":"131","author":"KS Oh","year":"2011","unstructured":"Oh KS, Emmert S, Tamura D, Digiovanna JJ, Kraemer KH. Multiple skin cancers in adults with mutations in the XP-E (DDB2) DNA repair gene. J Investig Dermatol. 2011;131:785\u20138.","journal-title":"J Investig Dermatol"},{"key":"900_CR56","first-page":"1","volume":"25","author":"KE Sharquie","year":"2022","unstructured":"Sharquie KE, Jabbar RI. Childhood and adult-onset xeroderma pigmentosum: clinical evaluation with striking new findings. Iran J Dermatol. 2022;25:1\u20138.","journal-title":"Iran J Dermatol"},{"key":"900_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/humu.22462","volume":"35","author":"K Opletalova","year":"2014","unstructured":"Opletalova K, Bourillon A, Yang W, Pouvelle C, Armier J, Despras E, et al. Correlation of phenotype\/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations. Hum Mutat. 2014;35:117\u201328. https:\/\/doi.org\/10.1002\/humu.22462.","journal-title":"Hum Mutat"},{"key":"900_CR58","first-page":"3410","volume":"7","author":"J-F Zheng","year":"2014","unstructured":"Zheng J-F, Mo H-Y, Wang Z-Z. Clinicopathological characteristics of xeroderma pigmentosum associated with keratoacanthoma: a case report and literature review. Int J Clin Exp Med. 2014;7:3410\u20134.","journal-title":"Int J Clin Exp Med"},{"key":"900_CR59","doi-asserted-by":"crossref","unstructured":"Bhat YJ. Xeroderma pigmentosum complicated by keratoacanthoma in a Kashmiri girl; 2018. Available from www.pigmentinternational.com. Accessed 10 Feb 2024.","DOI":"10.4103\/Pigmentinternational.Pigmentinternational_5_18"},{"key":"900_CR60","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/cup.13979","volume":"48","author":"C Baykal","year":"2021","unstructured":"Baykal C, Atc\u0131 T, Y\u0131lmaz Z, B\u00fcy\u00fckbabani N. Skin tumors in xeroderma pigmentosum: evaluation of a large series and a literature review. J Cutan Pathol. 2021;48:884\u201395. https:\/\/doi.org\/10.1111\/cup.13979.","journal-title":"J Cutan Pathol"},{"key":"900_CR61","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/jid.2014.311","volume":"135","author":"O Mama\u00ef","year":"2015","unstructured":"Mama\u00ef O, Boussofara L, Denguezli M, Escande-Beillard N, Kraeim W, Merriman B, et al. Multiple self-healing palmoplantar carcinoma: a familial predisposition to skin cancer with primary palmoplantar and conjunctival lesions. J Invest Dermatol. 2015;135:304.","journal-title":"J Invest Dermatol"},{"key":"900_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jdcr.2019.01.001","volume":"5","author":"C Scheufele","year":"2019","unstructured":"Scheufele C, Ezaldein HH, Rothbaum R, Delost GR. Multiple self-healing palmoplantar carcinoma: an aberrance of the inflammasome. JAAD Case Rep. 2019;5:261.","journal-title":"JAAD Case Rep"},{"key":"900_CR63","doi-asserted-by":"publisher","first-page":"100251","DOI":"10.1016\/j.jacig.2024.100251","volume":"3","author":"V Burlakov","year":"2024","unstructured":"Burlakov V, Kozlova A, Pershin D, Rodina Y, Khamin I, Novichkova G, et al. Combined therapy with IL-1 and JAK inhibitors in a patient with the NLRP1 gene mutation and a complex inflammatory phenotype. J Allergy Clin Immunol Glob. 2024;3:100251.","journal-title":"J Allergy Clin Immunol Glob"},{"key":"900_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-4632.2006.02948.x","volume":"46","author":"RJ Feldman","year":"2007","unstructured":"Feldman RJ, Maize JC. Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas. Int J Dermatol. 2007;46:77\u20139. https:\/\/doi.org\/10.1111\/j.1365-4632.2006.02948.x.","journal-title":"Int J Dermatol"},{"key":"900_CR65","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1111\/pde.13142","volume":"34","author":"B Barros","year":"2017","unstructured":"Barros B, Helm K, Zaenglein A, Seiverling E. Keratoacanthoma-like growths of incontinentia pigmenti successfully treated with intralesional methotrexate. Pediatr Dermatol. 2017;34:e203\u20134. https:\/\/doi.org\/10.1111\/pde.13142.","journal-title":"Pediatr Dermatol"},{"key":"900_CR66","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/ced.12053","volume":"38","author":"I Ballester Nortes","year":"2013","unstructured":"Ballester Nortes I, Allegue Gallego F, L\u00f5pez-\u00c1vila A, Ortiz Reina S, Requena CL. Painful subungual tumours. Clin Exp Dermatol. 2013;38:802\u20134. https:\/\/doi.org\/10.1111\/ced.12053.","journal-title":"Clin Exp Dermatol"},{"key":"900_CR67","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.0303-6987.2005.320hz.x","volume":"32","author":"A Young","year":"2005","unstructured":"Young A, Manolson P, Cohen B, Klapper M, Barrett T. Painful subungal dyskeratotic tumors in incontinentia pigmenti. J Cutan Pathol. 2005;32:122\u20133. https:\/\/doi.org\/10.1111\/j.0303-6987.2005.320hz.x.","journal-title":"J Cutan Pathol"},{"key":"900_CR68","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/01.DSS.0000452663.46669.26","volume":"40","author":"ZG Pena","year":"2014","unstructured":"Pena ZG, Brewer JD. Multiple subungual squamous cell carcinomas in a patient with incontinentia pigmenti. Dermatol Surg. 2014;40:1159\u201361.","journal-title":"Dermatol Surg"},{"key":"900_CR69","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.bjps.2007.09.050","volume":"61","author":"B Jamnadas","year":"2008","unstructured":"Jamnadas B, Agarwal R, Caddy CM. A rare case of SCC in a young patient with incontinentia pigmenti. J Plast Reconstr Aesthet Surg. 2008;61:973\u20134.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"900_CR70","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/ijd.12308","volume":"54","author":"A Nofal","year":"2015","unstructured":"Nofal A, Assaf M, Ghonemy S, Nofal E, Yosef A. Generalized eruptive keratoacanthoma: a diagnostic and therapeutic challenge. Int J Dermatol. 2015;54:160\u20137.","journal-title":"Int J Dermatol"},{"key":"900_CR71","unstructured":"Gay JT, Troxell T, Gross GP. Muir-Torre syndrome. StatPearls; 2023. Available from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513271\/. Accessed 24 Mar 2024."},{"key":"900_CR72","unstructured":"Online Mendelian Inheritance in Man, OMIM\u00ae. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD); 1987. World Wide Web. https:\/\/omim.org\/"},{"issue":"7","key":"900_CR73","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/jop.12256","volume":"44","author":"G Ponti","year":"2015","unstructured":"Ponti G, Meschieri A, Pollio A, et al. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy. J Oral Pathol Med. 2015;44(7):552\u20137. https:\/\/doi.org\/10.1111\/jop.12256. (Epub 2014 Sep 12 PMID: 25213213).","journal-title":"J Oral Pathol Med"},{"key":"900_CR74","unstructured":"Susannah Fraser, MBChB, FRCP (Edin), Consultant Dermatologist, NHS Fife, Scotland, United Kingdom; Chief Editor: Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, June 2015. DermNet NZ Revision July 2021"},{"key":"900_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000248665","volume":"176","author":"AL Wright","year":"1988","unstructured":"Wright AL, Gawkrodger DJ, Branford WA, McLaren K, Hunter JAA. Self-healing epitheliomata of Ferguson-Smith: cytogenetic and histological studies, and the therapeutic effect of etretinate. Dermatologica. 1988;176:22\u20138. https:\/\/doi.org\/10.1159\/000248665.","journal-title":"Dermatologica"},{"issue":"2\u20133","key":"900_CR76","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/phpp.12108","volume":"30","author":"D Tamura","year":"2014","unstructured":"Tamura D, DiGiovanna JJ, Khan SG, Kraemer KH. Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients: Living with xeroderma pigmentosum. Photodermatol Photoimmunol Photomed. 2014;30(2\u20133):146\u201352.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"25","key":"900_CR77","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","volume":"318","author":"KH Kraemer","year":"1988","unstructured":"Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988;318(25):1633\u20137.","journal-title":"N Engl J Med"},{"issue":"9","key":"900_CR78","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jid.2022.04.004","volume":"142","author":"G Fenini","year":"2022","unstructured":"Fenini G, Karakaya T, Hennig P, Di Filippo M, Slaufova M, Beer HD. NLRP1 inflammasome activation in keratinocytes: increasing evidence of important roles in inflammatory skin diseases and immunity. J Invest Dermatol. 2022;142(9):2313\u201322. https:\/\/doi.org\/10.1016\/j.jid.2022.04.004. (Epub 2022 May 9 PMID: 35550825).","journal-title":"J Invest Dermatol"},{"issue":"3","key":"900_CR79","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1111\/ijd.13893","volume":"57","author":"R Bednarek","year":"2018","unstructured":"Bednarek R, Marks K, Lin G. Eruptive keratoacanthomas secondary to nivolumab immunotherapy. Int J Dermatol. 2018;57(3):e28\u20139. https:\/\/doi.org\/10.1111\/ijd.13893. (Epub 2018 Jan 10 PMID: 29318617).","journal-title":"Int J Dermatol"},{"issue":"13","key":"900_CR80","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2340\/00015555-3301","volume":"99","author":"M Fradet","year":"2019","unstructured":"Fradet M, Sibaud V, Tournier E, et al. Multiple keratoacanthoma-like lesions in a patient treated with pembrolizumab. Acta Derm Venereol. 2019;99(13):1301\u20132. https:\/\/doi.org\/10.2340\/00015555-3301. (PMID: 31449315).","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"900_CR81","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/jamadermatol.2017.0989","volume":"153","author":"A Freites-Martinez","year":"2017","unstructured":"Freites-Martinez A, Kwong BY, Rieger KE, Coit DG, Colevas AD, Lacouture ME. Eruptive keratoacanthomas associated with pembrolizumab therapy. JAMA Dermatol. 2017;153(7):694\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0989. (PMID: 28467522; PMCID: PMC5523926).","journal-title":"JAMA Dermatol"},{"issue":"5","key":"900_CR82","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1365-2133.2012.11155.x","volume":"167","author":"RM Anforth","year":"2012","unstructured":"Anforth RM, Blumetti TC, Kefford RF, et al. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma. Br J Dermatol. 2012;167(5):1153\u201360. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11155.x. (Epub 2012 Oct 5 PMID: 22804352).","journal-title":"Br J Dermatol"},{"issue":"26","key":"900_CR83","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, et al. BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1103782.","journal-title":"N Engl J Med"},{"issue":"23","key":"900_CR84","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1200\/JCO.2009.23.4823","volume":"27","author":"JP Arnault","year":"2009","unstructured":"Arnault JP, Wechsler J, Escudier B, et al. Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib. J Clin Oncol. 2009;27(23):e59\u201361. https:\/\/doi.org\/10.1200\/JCO.2009.23.4823.","journal-title":"J Clin Oncol"},{"issue":"5","key":"900_CR85","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1111\/1346-8138.16699","volume":"50","author":"K Kosaka","year":"2023","unstructured":"Kosaka K, Yasuda M, Kim J, et al. Multiple keratoacanthomas induced by treatment with dasatinib and bosutinib for chronic myeloid leukemia: a case report and literature review. J Dermatol. 2023;50(5):e171\u20132. https:\/\/doi.org\/10.1111\/1346-8138.16699.","journal-title":"J Dermatol"},{"issue":"2","key":"900_CR86","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1001\/jamadermatol.2013.1798","volume":"149","author":"S Aasi","year":"2013","unstructured":"Aasi S, Silkiss R, Tang JY, et al. New onset of keratoacanthomas after vismodegib treatment for locally advanced basal cell carcinomas: a report of 2 cases. JAMA Dermatol. 2013;149(2):242\u20133. https:\/\/doi.org\/10.1001\/jamadermatol.2013.1798. (PMID: 23426496; PMCID: PMC3768013).","journal-title":"JAMA Dermatol"},{"issue":"10","key":"900_CR87","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1691\/ph.2022.2453","volume":"77","author":"H Tanaka","year":"2022","unstructured":"Tanaka H, Okuma M, Ishii T. Occurrence of voriconazole-induced cutaneous squamous cell carcinoma in Japan: data mining from different national pharmacovigilance databases. Pharmazie. 2022;77(10):307\u201310. https:\/\/doi.org\/10.1691\/ph.2022.2453. (PMID: 36273254).","journal-title":"Pharmazie"},{"issue":"7","key":"900_CR88","doi-asserted-by":"publisher","first-page":"18968","DOI":"10.5070\/D3197018968","volume":"19","author":"L Frances","year":"2013","unstructured":"Frances L, Guijarro J, Marin I, Leiva-Salinas Mdel C, Bouret AM. Multiple eruptive keratoacanthomas associated with leflunomide. Dermatol Online J. 2013;19(7):18968 (PMID: 24010514).","journal-title":"Dermatol Online J"},{"issue":"5 Suppl","key":"900_CR89","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.jaad.2003.11.044","volume":"50","author":"AC Esser","year":"2004","unstructured":"Esser AC, Abril A, Fayne S, Doyle JA. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol. 2004;50(5 Suppl):S75\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2003.11.044. (PMID: 15097933).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"900_CR90","doi-asserted-by":"publisher","DOI":"10.2196\/41739","volume":"5","author":"F Ahmed","year":"2022","unstructured":"Ahmed F, Memon N, Haque A. Multiple keratoacanthomas following Moderna messenger RNA-1273 COVID-19 vaccination resolved with 5-fluorouracil treatment: case report. JMIR Dermatol. 2022;5(4): e41739. https:\/\/doi.org\/10.2196\/41739.","journal-title":"JMIR Dermatol"},{"issue":"4","key":"900_CR91","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00262-015-1653-0","volume":"64","author":"ME Lacouture","year":"2015","unstructured":"Lacouture ME, Morris JC, Lawrence DP, et al. Cutaneous keratoacanthomas\/squamous cell carcinomas associated with neutralization of transforming growth factor \u03b2 by the monoclonal antibody fresolimumab (GC1008). Cancer Immunol Immunother. 2015;64(4):437\u201346. https:\/\/doi.org\/10.1007\/s00262-015-1653-0. (Epub 2015 Jan 13. PMID: 25579378; PMCID: PMC6730642).","journal-title":"Cancer Immunol Immunother"},{"key":"900_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jdcr.2021.08.001","volume":"16","author":"E Cruzval-O\u2019Reilly","year":"2021","unstructured":"Cruzval-O\u2019Reilly E, Ro T, Jolly PS. Eruptive keratoacanthomas secondary to topical 5-fluorouracil application. JAAD Case Rep. 2021;16:19\u201321. https:\/\/doi.org\/10.1016\/j.jdcr.2021.08.001.","journal-title":"JAAD Case Rep"},{"issue":"5","key":"900_CR93","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2230.2012.04476.x","volume":"38","author":"E Campalani","year":"2013","unstructured":"Campalani E, Holden CA. Keratoacanthoma associated with the use of topical imiquimod. Clin Exp Dermatol. 2013;38(5):555\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.2012.04476.x.","journal-title":"Clin Exp Dermatol"},{"issue":"5 Suppl","key":"900_CR94","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1016\/j.jaad.2008.06.018","volume":"59","author":"AM Pini","year":"2008","unstructured":"Pini AM, Koch S, Sch\u00e4rer L, French LE, L\u00e4uchli S, Hofbauer GF. Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient. J Am Acad Dermatol. 2008;59(5 Suppl):S116\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2008.06.018. (PMID: 19119118).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"900_CR95","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2340\/00015555-0109","volume":"86","author":"S D\u2019Addario","year":"2006","unstructured":"D\u2019Addario S, Carrington PR. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses. Acta Derm Venereol. 2006;86(4):366\u20137. https:\/\/doi.org\/10.2340\/00015555-0109.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"900_CR96","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/s0190-9622(83)70181-7","volume":"9","author":"B Sina","year":"1983","unstructured":"Sina B, Adrian RM. Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapy. J Am Acad Dermatol. 1983;9(5):686\u20138. https:\/\/doi.org\/10.1016\/s0190-9622(83)70181-7. (PMID: 6643766).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"900_CR97","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10227-004-0122-8","volume":"8","author":"KJ Craddock","year":"2004","unstructured":"Craddock KJ, Rao J, Lauzon GJ, Tron VA. Multiple keratoacanthomas arising post-UVB therapy. J Cutan Med Surg. 2004;8(4):239\u201343. https:\/\/doi.org\/10.1007\/s10227-004-0122-8. (PMID: 16092002).","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"900_CR98","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1046\/j.1524-4725.1999.99072.x","volume":"25","author":"A Gewirtzman","year":"1999","unstructured":"Gewirtzman A, Meirson DH, Rabinovitz H. Eruptive keratoacanthomas following carbon dioxide laser resurfacing. Dermatol Surg. 1999;25(8):666\u20138. https:\/\/doi.org\/10.1046\/j.1524-4725.1999.99072.x. (PMID: 10491052).","journal-title":"Dermatol Surg"},{"issue":"2","key":"900_CR99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1468-3083.2005.01370.x","volume":"20","author":"AF Kaptanoglu","year":"2006","unstructured":"Kaptanoglu AF, Kutluay L. Keratoacanthoma developing in previous cryotherapy site for solar keratosis. J Eur Acad Dermatol Venereol. 2006;20(2):197\u20138. https:\/\/doi.org\/10.1111\/j.1468-3083.2005.01370.x. (PMID: 16441631).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 Pt 2","key":"900_CR100","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/0190-9622(90)70324-b","volume":"23","author":"JC Shaw","year":"1990","unstructured":"Shaw JC, Storrs FJ, Everts E. Multiple keratoacanthomas after megavoltage radiation therapy. J Am Acad Dermatol. 1990;23(5 Pt 2):1009\u201311. https:\/\/doi.org\/10.1016\/0190-9622(90)70324-b. (PMID: 2121805).","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"900_CR101","first-page":"450","volume":"20","author":"LS Baumann","year":"2007","unstructured":"Baumann LS, Romanelli P, Marangoni O. Keratoacanthomas as a complication of dermal filler injections. Cosmet Dermatol. 2007;20(7):450\u20132.","journal-title":"Cosmet Dermatol"},{"issue":"2","key":"900_CR102","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1524-4725.2003.29030.x","volume":"29","author":"S Cox","year":"2003","unstructured":"Cox S. Rapid development of keratoacanthomas after a body peel. Dermatol Surg. 2003;29(2):201\u20133. https:\/\/doi.org\/10.1046\/j.1524-4725.2003.29030.x. (PMID: 12562357).","journal-title":"Dermatol Surg"},{"issue":"2 Suppl","key":"900_CR103","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1067\/mjd.2003.114","volume":"48","author":"SF Pattee","year":"2003","unstructured":"Pattee SF, Silvis NG. Keratoacanthoma developing in sites of previous trauma: a report of two cases and review of the literature. J Am Acad Dermatol. 2003;48(2 Suppl):S35\u20138. https:\/\/doi.org\/10.1067\/mjd.2003.114. (PMID: 12582383).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"900_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-0560.2009.01286.x","volume":"37","author":"GR Fraga","year":"2010","unstructured":"Fraga GR, Prossick TA. Tattoo-associated keratoacanthomas: a series of 8 patients with 11 keratoacanthomas. J Cutan Pathol. 2010;37(1):85\u201390. https:\/\/doi.org\/10.1111\/j.1600-0560.2009.01286.x. (Epub 2009 Mar 19 PMID: 19302572).","journal-title":"J Cutan Pathol"},{"issue":"6","key":"900_CR105","first-page":"410","volume":"47","author":"WM Hendricks","year":"1991","unstructured":"Hendricks WM. Sudden appearance of multiple keratoacanthomas three weeks after thermal burns. Cutis. 1991;47(6):410\u20132 (PMID: 1879178).","journal-title":"Cutis"},{"issue":"1","key":"900_CR106","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/0019-5154.174058","volume":"61","author":"S Sen","year":"2016","unstructured":"Sen S, Samanta A, Majumdar B, Jain A, Behra A, Mishra P. \u201cNevoid eruptive keratoacanthoma\u201d\u2014yet another atypical manifestation of generalized keratoacanthoma. Indian J Dermatol. 2016;61(1):106\u20137. https:\/\/doi.org\/10.4103\/0019-5154.174058. (PMID: 26955113; PMCID: PMC4763622).","journal-title":"Indian J Dermatol"},{"issue":"9","key":"900_CR107","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-4362.1980.tb00365.x","volume":"19","author":"AR Ahmed","year":"1980","unstructured":"Ahmed AR. Multiple keratoacanthoma. Int J Dermatol. 1980;19(9):496\u20139. https:\/\/doi.org\/10.1111\/j.1365-4362.1980.tb00365.x. (PMID: 7000722).","journal-title":"Int J Dermatol"},{"issue":"3","key":"900_CR108","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1001\/archderm.93.3.348","volume":"93","author":"HW Jolly Jr","year":"1966","unstructured":"Jolly HW Jr, Carpenter CL Jr. Multiple keratoacanthomata. A report of two cases. Arch Dermatol. 1966;93(3):348\u201353. https:\/\/doi.org\/10.1001\/archderm.93.3.348. (PMID: 5910879).","journal-title":"Arch Dermatol"},{"key":"900_CR109","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2133.1961.tb14418.x","volume":"73","author":"CF Vickers","year":"1961","unstructured":"Vickers CF, Ghadially FN. Keratoacanthomata associated with psoriasis. Br J Dermatol. 1961;73:120\u20134. https:\/\/doi.org\/10.1111\/j.1365-2133.1961.tb14418.x. (PMID: 13781156).","journal-title":"Br J Dermatol"},{"issue":"4 Pt 1","key":"900_CR110","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/s0190-9622(89)80282-8","volume":"21","author":"PA Fanti","year":"1989","unstructured":"Fanti PA, Tosti A, Peluso AM, Bonelli U. Multiple keratoacanthoma in discoid lupus erythematosus. J Am Acad Dermatol. 1989;21(4 Pt 1):809\u201310. https:\/\/doi.org\/10.1016\/s0190-9622(89)80282-8. (PMID: 2808804).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"900_CR111","doi-asserted-by":"publisher","first-page":"221","DOI":"10.12788\/cutis.0221","volume":"107","author":"MB Downing","year":"2021","unstructured":"Downing MB, Prouty M, Wu DJ, Rajpara A. High-potency topical steroid treatment of multiple keratoacanthomas associated with prurigo nodularis. Cutis. 2021;107(4):221\u20132. https:\/\/doi.org\/10.12788\/cutis.0221. (PMID: 34096850).","journal-title":"Cutis"},{"issue":"3","key":"900_CR112","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jaad.2013.03.035","volume":"69","author":"TP Wu","year":"2013","unstructured":"Wu TP, Miller K, Cohen DE, Stein JA. Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin. J Am Acad Dermatol. 2013;69(3):426\u201330. https:\/\/doi.org\/10.1016\/j.jaad.2013.03.035. (Epub 2013 May 10 PMID: 23664628).","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"900_CR113","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1046\/j.1365-2133.2000.03319.x","volume":"142","author":"A Badell","year":"2000","unstructured":"Badell A, Marcoval J, Gallego I, Moreno A, Peyr\u00ed J. Keratoacanthoma arising in hypertrophic lichen planus. Br J Dermatol. 2000;142(2):380\u20132. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03319.x.","journal-title":"Br J Dermatol"},{"issue":"12","key":"900_CR114","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/archderm.1981.01650120034017","volume":"117","author":"BL Snider","year":"1981","unstructured":"Snider BL, Benjamin DR. Eruptive keratoacanthoma with an internal malignant neoplasm. Arch Dermatol. 1981;117(12):788\u201390 (PMID: 7316554).","journal-title":"Arch Dermatol"},{"issue":"1","key":"900_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30363-X","volume":"8","author":"P Zhu","year":"2021","unstructured":"Zhu P, Wang Y. Multiple keratoacanthomas in a patient with myelodysplastic syndrome. Lancet Haematol. 2021;8(1): e94. https:\/\/doi.org\/10.1016\/S2352-3026(20)30363-X. (Epub 2020 Dec 22. PMID: 33357488).","journal-title":"Lancet Haematol"},{"issue":"7","key":"900_CR116","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1034\/j.1600-0560.2003.00092.x","volume":"30","author":"O Forslund","year":"2003","unstructured":"Forslund O, DeAngelis PM, Beigi M, Schj\u00f8lberg AR, Clausen OP. Identification of human papillomavirus in keratoacanthomas. J Cutan Pathol. 2003;30(7):423\u20139. https:\/\/doi.org\/10.1034\/j.1600-0560.2003.00092.x. (PMID: 12859739).","journal-title":"J Cutan Pathol"}],"updated-by":[{"DOI":"10.1007\/s40257-025-00921-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000}}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-024-00900-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:15:31Z","timestamp":1739200531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-024-00900-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1007\/s40257-024-00900-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40257-025-00921-3","asserted-by":"object"}]},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"26 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40257-025-00921-3","URL":"https:\/\/doi.org\/10.1007\/s40257-025-00921-3","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for conducting this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Data sharing is not applicable to this article as no new data were created or analysed in this study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors have made substantial contributions to the work and have approved the final version of this article. A.D. had the idea for this study. A.D., R.I.N., G.Tur., I.S., G.Tud. and A.A. reviewed the relevant literature. A.D., R.I.N., A.B., I.H., E.B., T.E.F., M.G., C.H., D.A.I. and A.M.F. edited and approved the final draft. D.A.I. and A.M.F. contributed equally to this study and share senior authorship.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}